Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 7/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.39 |
| ▸ | CNR2 | P34972 | 5/20 | 0.36 |
| ▸ | CNR1 | P21554 | 5/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3103712 | 0.88 | OPRL1 (0.39) | OPRL1KCNH2CNR2CNR1 | |
| SCHEMBL3103491 | 0.81 | OPRL1 (0.36) | OPRL1KCNH2CNR2CNR1 | |
| SCHEMBL3100716 | 0.79 | CNR2 (0.39) | OPRL1KCNH2CNR2CNR1 | |
| SCHEMBL3094639 | 0.79 | CNR2 (0.47) | CNR2CNR1 | |
| SCHEMBL3096422 | 0.78 | CNR2 (0.48) | CNR2CNR1 | |
| SCHEMBL3087634 | 0.77 | CNR1 (0.47) | OPRL1KCNH2CNR2CNR1 | |
| SCHEMBL3089140 | 0.76 | CNR1 (0.49) | OPRL1KCNH2CNR2CNR1 | |
| SCHEMBL3096383 | 0.76 | KDM4E (0.52) | CNR2CNR1 | |
| SCHEMBL3092984 | 0.75 | ALOX12 (0.49) | OPRL1KCNH2CNR2CNR1 | |
| SCHEMBL3096369 | 0.75 | CNR1 (0.49) | OPRL1KCNH2CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2012149-B1 | RETARDATION FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY | KONICA MINOLTA OPTO INC (JP) | 2018-02-14 | — | — | EP | disclosed |
| US-9272448-B2 | Cellulose resin film, process for producing cellulose resin film, antireflection film, polarizing plate, and liquid crystal display | KONICA MINOLTA OPTO, INC. (JP) | 2016-03-01 | — | — | US | disclosed |
| US-9243131-B2 | Retardation film, polarizing plate and liquid crystal display device | KONICA MINOLTA OPTO, INC. (JP) | 2016-01-26 | — | — | US | disclosed |
| US-7803293-B2 | Optical film manufacturing method, optical film manufacturing apparatus and optical film | KONICA MINOLTA OPTO, INC. (JP) | 2010-09-28 | — | — | US | disclosed |
| US-7803799-B2 | such as 1-(2,4-dichlorophenyl)-N-(piperidin-1-yl)-5-(selenophen-2-yl)-1H-pyrazole-3-carboxamide, used for treating cannabinoid-receptor mediated disorders selected from obesity, metabolic syndrome, drug abuse and dependence or neuropathic pain | NATIONAL HEALTH RESEARCH INSTITUTES (TW) | 2010-09-28 | — | — | US | disclosed |
| US-7495720-B2 | Polarizing plate and liquid crystal display device | KONICA MINOLTA OPTO, INC. (JP) | 2009-02-24 | — | — | US | disclosed |
| EP-2012149-A1 | RETARDATION FILM, POLARIZING PLATE AND LIQUID CRYSTAL DISPLAY | Konica Minolta Opto, Inc. (JP) | 2009-01-07 | — | — | EP | disclosed |
| US-20080246189-A1 | Cellulose Resin Film, Process for Producing Cellulose Resin Film, Antireflection Film, Polarizing Plate, and Liquid Crystal Display | KONICA MINOLTA OPTO, INC. (JP) | 2008-10-09 | — | — | US | disclosed |
| US-20080021031-A1 | SELENOPHENE COMPOUNDS | NATIONAL HEALTH RESEARCH INSTITUTE (TW) | 2008-01-24 | — | — | US | disclosed |
| US-20070247576-A1 | Retardation film, polarizing plate and liquid crystal display device | KONICA MINOLTA OPTO, INC. (JP) | 2007-10-25 | — | — | US | disclosed |
| US-20070085228-A1 | OPTICAL FILM MANUFACTURING METHOD, OPTICAL FILM MANUFACTURING APPARATUS AND OPTICAL FILM | KONICA MINOLTA OPTO, INC. (JP) | 2007-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080021031-A1 | SELENOPHENE COMPOUNDS | CNR2, CNR1, SELENOI | OPRL1 14/4885KCNH2 3042/4885CNR2 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.